JLE

Néphrologie & Thérapeutique

MENU

Is peritoneal dialysis a therapeutic option for polycystic kidney disease? 15 years’ experience in a single center Volume 12, issue 4, Juillet 2016

Figures


  • Fig. 1

  • Fig. 2

Tables


  • Table 1

  • Table 2

  • Table 3
Authors

1 IntroductionAutosomal dominant polycystic kidney disease (PKD) is the most common hereditary kidney disease [1]. It is the fourth leading cause of end-stage renal disease (ESRD) according to US Renal Data System (USRDS) just after diabetes, hypertension, and glomerulonephritis [2].The choice of modality for renal replacement therapy in patients with PKD varies, often based on patients’ choice, physician-related factors, and dialysis centers’ distance to the patient. The choice of initiating peritoneal [...]